statistiche ricercatore

Continente	#
NA - Nord America	557
EU - Europa	554
AS - Asia	295
SA - Sud America	103
AF - Africa	13
Continente sconosciuto - Info sul continente non disponibili	12
OC - Oceania	4
Totale	1.538

Nazione	#
US - Stati Uniti d'America	543
PL - Polonia	192
IT - Italia	147
RU - Federazione Russa	111
VN - Vietnam	80
BR - Brasile	79
SG - Singapore	64
CN - Cina	48
HK - Hong Kong	40
IE - Irlanda	25
KR - Corea	20
ES - Italia	16
FR - Francia	13
FI - Finlandia	11
GB - Regno Unito	10
IN - India	10
CA - Canada	9
DE - Germania	8
EC - Ecuador	7
ID - Indonesia	7
SE - Svezia	7
BD - Bangladesh	5
CO - Colombia	5
ZA - Sudafrica	4
AR - Argentina	3
AU - Australia	3
CH - Svizzera	3
CL - Cile	3
JO - Giordania	3
JP - Giappone	3
NL - Olanda	3
NP - Nepal	3
PK - Pakistan	3
RO - Romania	3
TN - Tunisia	3
UA - Ucraina	3
MX - Messico	2
PE - Perù	2
PS - Palestinian Territory	2
PY - Paraguay	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
AZ - Azerbaigian	1
BE - Belgio	1
BN - Brunei Darussalam	1
CG - Congo	1
CI - Costa d'Avorio	1
CR - Costa Rica	1
EG - Egitto	1
EU - Europa	1
GR - Grecia	1
IL - Israele	1
IQ - Iraq	1
KE - Kenya	1
NG - Nigeria	1
NI - Nicaragua	1
NZ - Nuova Zelanda	1
RE - Reunion	1
TT - Trinidad e Tobago	1
TW - Taiwan	1
UZ - Uzbekistan	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	1.528

Nome	#
Functional omics approaches towards affected molecular pathways underlying various forms of Neuronal Ceroid Lipofuscinoses	383
The networks of genes encoding palmitoylated proteins in axonal and synaptic compartments are affected in PPT1 overexpressing neuronal-like cells	236
Mitochondrial respiratory chain defects in skin fibroblasts from patients with Dravet syndrome	185
Additive effect of DNAJC30 and NDUFA9 mutations causing Leigh syndrome	167
Bi-allelic variants in MTMR5/SBF1 cause Charcot-Marie-Tooth type 4B3 featuring mitochondrial dysfunction	166
Early infantile neuronal ceroid lipofuscinosis (CLN10 disease) associated with a novel mutation in CTSD	161
ANNUAL REPORT - IN VITRO STUDIES OF ENERGY DYSFUNCTION IN CLASSICAL-INFANTILE AND LATE-INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	128
Annual report - Proteomic analysis and molecular pathways in models of CLN5 disease	112
Totale	1.538

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	38	0	3	2	5	0	0	0	6	1	4	3	14
2022/2023	109	21	10	2	6	5	20	12	5	12	4	8	4
2023/2024	70	5	5	15	1	5	0	6	23	0	1	3	6
2024/2025	455	14	48	21	55	150	98	10	26	10	6	7	10
2025/2026	445	17	48	46	123	40	18	36	15	23	21	5	53
2026/2027	39	34	5	0	0	0	0	0	0	0	0	0	0
Totale													1.538